<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
<META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW, NOARCHIVE">
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<title>Armstrong v. Cenenary Health Centre (June 13, 2005)</title>
<style><!--
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:15.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-font-kerning:0pt;
	font-weight:normal;}
h2
	{mso-style-next:Normal;
	text-align:center;
	line-height:200%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:15.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-bidi-font-weight:normal;}
h3
	{mso-style-next:Normal;
	text-align:justify;
	mso-pagination:widow-orphan;
	mso-outline-level:3;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-bidi-font-weight:normal;}
h4
	{mso-style-next:Normal;
	text-align:justify;
	line-height:200%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-bidi-font-weight:normal;}
h5
	{mso-style-next:Normal;
	text-align:right;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-bidi-font-weight:normal;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{text-align:justify;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
span.MsoFootnoteReference
	{vertical-align:super;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{text-align:justify;
	mso-pagination:widow-orphan;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.Doubleindent-quote, li.Doubleindent-quote, div.Doubleindent-quote
	{mso-style-name:"Double indent-quote";
	text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:1.5in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.Double-indent-subquote, li.Double-indent-subquote, div.Double-indent-subquote
	{mso-style-name:Double-indent-subquote;
	mso-style-parent:"";
	text-align:justify;
	mso-pagination:none;
	tab-stops:2.0in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.headingNUMBER, li.headingNUMBER, div.headingNUMBER
	{mso-style-name:"heading\: NUMBER";
	mso-style-update:auto;
	text-align:justify;
	text-indent:0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	mso-list:l18 level2 lfo70;
	tab-stops:.5in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.ParaNO, li.ParaNO, div.ParaNO
	{mso-style-name:"Para NO \#";
	mso-style-parent:"heading\: NUMBER";
	text-align:justify;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
@page Section1
	{size:8.5in 11.0in;
	mso-header-
	mso-footer-
	mso-page-numbers:1;
	mso-title-page:yes;
	mso-even-header: url() eh1;
	mso-header: url() h1;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
@list l0
	{mso-list-id:-131;
	mso-list-type:simple;
	mso-list-template-ids:1265521074;}
@list l0:level1
	{mso-level-tab-stop:60.45pt;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l1
	{mso-list-id:8877544;
	mso-list-type:hybrid;
	mso-list-template-ids:1963475592 -378473860 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.6in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2
	{mso-list-id:93061649;
	mso-list-type:hybrid;
	mso-list-template-ids:-776858408 67698693 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l3
	{mso-list-id:131873944;
	mso-list-type:hybrid;
	mso-list-template-ids:-1925158090 67698693 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l4
	{mso-list-id:165751720;
	mso-list-type:hybrid;
	mso-list-template-ids:1963475592 67698693 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:42.95pt;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l5
	{mso-list-id:246421916;
	mso-list-type:hybrid;
	mso-list-template-ids:-218730750 -1313171454 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l5:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l6
	{mso-list-id:248387907;
	mso-list-template-ids:-853636652;}
@list l6:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l6:level2
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l6:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l6:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l6:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l6:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:.5in;}
@list l6:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l6:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l6:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l7
	{mso-list-id:303048637;
	mso-list-type:hybrid;
	mso-list-template-ids:1915665492 67698693 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l8
	{mso-list-id:339309350;
	mso-list-template-ids:-1534701368;}
@list l8:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l8:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l8:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l8:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l8:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l8:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:.5in;}
@list l8:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l8:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l8:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l9
	{mso-list-id:388502664;
	mso-list-type:simple;
	mso-list-template-ids:-1467875128;}
@list l9:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-3.5in;
	font-family:Symbol;}
@list l10
	{mso-list-id:408885235;
	mso-list-type:hybrid;
	mso-list-template-ids:1963475592 149424454 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l10:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:42.95pt;
	mso-level-number-position:left;
	text-indent:-14.65pt;
	font-family:Wingdings;}
@list l11
	{mso-list-id:428283389;
	mso-list-type:hybrid;
	mso-list-template-ids:683187248 1838048632 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l11:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.2in;
	font-family:Wingdings;}
@list l11:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l12
	{mso-list-id:512719479;
	mso-list-type:hybrid;
	mso-list-template-ids:-835438190 67698693 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l12:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l13
	{mso-list-id:527061025;
	mso-list-template-ids:2061530658;}
@list l13:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level4
	{mso-level-reset-level:level1;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l14
	{mso-list-id:554856912;
	mso-list-type:hybrid;
	mso-list-template-ids:683187248 441502738 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l14:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l14:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15
	{mso-list-id:567962766;
	mso-list-type:hybrid;
	mso-list-template-ids:-1630906798 -2033696122 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l15:level1
	{mso-level-start-at:3;
	mso-level-number-format:roman-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l16
	{mso-list-id:632907181;
	mso-list-type:hybrid;
	mso-list-template-ids:1809068266 -382541492 -887082436 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l16:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l16:level2
	{mso-level-text:"%2\)";
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l17
	{mso-list-id:723064315;
	mso-list-type:hybrid;
	mso-list-template-ids:1963475592 -109798580 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l17:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.7in;
	mso-level-number-position:left;
	text-indent:-25.45pt;
	font-family:Wingdings;}
@list l18
	{mso-list-id:727992645;
	mso-list-template-ids:-1413452760;}
@list l18:level1
	{mso-level-start-at:6;
	mso-level-style-link:"heading\: NUMBER";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l18:level2
	{mso-level-reset-level:level1;
	mso-level-style-link:"heading\: NUMBER";
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;
	mso-ansi-font-size:13.0pt;
	font-family:"Times New Roman";
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;}
@list l18:level3
	{mso-level-tab-stop:.6in;
	mso-level-number-position:left;
	text-indent:-.55in;}
@list l18:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l18:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l18:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:.5in;}
@list l18:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l18:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l18:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l19
	{mso-list-id:734011220;
	mso-list-template-ids:486683052;}
@list l19:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l19:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l19:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-style-link:Normal;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l19:level4
	{mso-level-reset-level:level1;
	mso-level-style-link:Normal;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l19:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l19:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:.5in;}
@list l19:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l19:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l19:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l20
	{mso-list-id:746270875;
	mso-list-type:hybrid;
	mso-list-template-ids:-1470047180 67698693 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l20:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l21
	{mso-list-id:764231896;
	mso-list-template-ids:1352008676;}
@list l21:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l21:level2
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l21:level3
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"%3\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l21:level4
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%4\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l21:level5
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l21:level6
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l21:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l21:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l21:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l22
	{mso-list-id:864296457;
	mso-list-type:hybrid;
	mso-list-template-ids:-1655821766 441502738 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l22:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l23
	{mso-list-id:870804388;
	mso-list-type:hybrid;
	mso-list-template-ids:1924300316 67698693 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l23:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l24
	{mso-list-id:890728182;
	mso-list-type:simple;
	mso-list-template-ids:-940518988;}
@list l24:level1
	{mso-level-text:"\[%1\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;}
@list l25
	{mso-list-id:911693226;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l25:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l26
	{mso-list-id:932279897;
	mso-list-type:hybrid;
	mso-list-template-ids:332201808 67698693 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l26:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l27
	{mso-list-id:1041132961;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l27:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l28
	{mso-list-id:1093624493;
	mso-list-type:hybrid;
	mso-list-template-ids:555379540 240305508 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l28:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:93.0pt;
	mso-level-number-position:left;
	text-indent:-21.0pt;}
@list l29
	{mso-list-id:1135607938;
	mso-list-type:simple;
	mso-list-template-ids:1707907966;}
@list l29:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-weight:bold;}
@list l30
	{mso-list-id:1236354383;
	mso-list-type:simple;
	mso-list-template-ids:-225288742;}
@list l30:level1
	{mso-level-text:"\[%1\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;}
@list l31
	{mso-list-id:1250120100;
	mso-list-template-ids:-2020592624;
	mso-list-name:QUOTE;}
@list l31:level1
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l31:level2
	{mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l31:level3
	{mso-level-number-format:none;
	mso-level-text:%3;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l31:level4
	{mso-level-suffix:none;
	mso-level-text:"\(%4\)\0009";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l31:level5
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%5\)\0009";
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l31:level6
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l31:level7
	{mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l31:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l31:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l32
	{mso-list-id:1272935038;
	mso-list-type:hybrid;
	mso-list-template-ids:555132968 441502738 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l32:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l33
	{mso-list-id:1296107855;
	mso-list-type:simple;
	mso-list-template-ids:-1612034996;}
@list l33:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l34
	{mso-list-id:1315601249;
	mso-list-type:simple;
	mso-list-template-ids:-52672024;}
@list l34:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l35
	{mso-list-id:1351223800;
	mso-list-type:hybrid;
	mso-list-template-ids:555132968 1838048632 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l35:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.45in;
	mso-level-number-position:left;
	text-indent:-.2in;
	font-family:Wingdings;}
@list l36
	{mso-list-id:1360743876;
	mso-list-type:hybrid;
	mso-list-template-ids:1963475592 8035738 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l36:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:42.95pt;
	mso-level-number-position:left;
	text-indent:-14.65pt;
	font-family:Wingdings;}
@list l37
	{mso-list-id:1364986882;
	mso-list-type:hybrid;
	mso-list-template-ids:-1889232342 67698693 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l37:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l38
	{mso-list-id:1372729403;
	mso-list-type:hybrid;
	mso-list-template-ids:1963475592 606101090 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l38:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:42.95pt;
	mso-level-number-position:left;
	text-indent:-3.85pt;
	font-family:Wingdings;}
@list l39
	{mso-list-id:1379082856;
	mso-list-type:hybrid;
	mso-list-template-ids:1390853604 -1097846680 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l39:level1
	{mso-level-number-format:roman-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l40
	{mso-list-id:1383941449;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l40:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l41
	{mso-list-id:1395616703;
	mso-list-type:hybrid;
	mso-list-template-ids:-1655821766 1838048632 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l41:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.2in;
	font-family:Wingdings;}
@list l42
	{mso-list-id:1491293457;
	mso-list-type:hybrid;
	mso-list-template-ids:-429645818 1979505532 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l42:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%1\)";
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l43
	{mso-list-id:1509170297;
	mso-list-template-ids:-1137539842;}
@list l43:level1
	{mso-level-text:"\[%1\]     ";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l43:level2
	{mso-level-number-format:none;
	mso-level-text:%2;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l43:level3
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%3\)";
	mso-level-tab-stop:.9in;
	mso-level-number-position:left;
	text-indent:-.4in;}
@list l43:level4
	{mso-level-text:"%4\)";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l43:level5
	{mso-level-text:%5;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l43:level6
	{mso-level-text:%6;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l43:level7
	{mso-level-text:%7;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l43:level8
	{mso-level-text:%8;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l43:level9
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l44
	{mso-list-id:1550385919;
	mso-list-template-ids:821708086;}
@list l44:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l44:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l44:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l44:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l44:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l44:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l44:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l44:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l44:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l45
	{mso-list-id:1602642375;
	mso-list-type:hybrid;
	mso-list-template-ids:-710242626 1140866708 -1691440576 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l45:level1
	{mso-level-number-format:roman-upper;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l45:level2
	{mso-level-number-format:roman-lower;
	mso-level-text:"%2\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l46
	{mso-list-id:1665664019;
	mso-list-template-ids:-1754337048;}
@list l46:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l46:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l46:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l46:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l46:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l46:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l46:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l46:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l46:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l47
	{mso-list-id:1682200304;
	mso-list-template-ids:426402662;}
@list l47:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l47:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l47:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l47:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l47:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l47:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:.5in;}
@list l47:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l47:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l47:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l48
	{mso-list-id:1752388551;
	mso-list-type:hybrid;
	mso-list-template-ids:1963475592 67698693 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l48:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:42.95pt;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l49
	{mso-list-id:1758019210;
	mso-list-type:hybrid;
	mso-list-template-ids:-407842294 67698693 67698699 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l49:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l49:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0D8;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l50
	{mso-list-id:1782457026;
	mso-list-type:simple;
	mso-list-template-ids:1131831968;}
@list l50:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l51
	{mso-list-id:1785883979;
	mso-list-template-ids:1689811090;}
@list l51:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"\(%1\)";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l51:level2
	{mso-level-number-format:none;
	mso-level-text:%2;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l51:level3
	{mso-level-number-format:alpha-lower;
	mso-level-text:"\(%3\)";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l51:level4
	{mso-level-number-format:none;
	mso-level-text:"\(i\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:.5in;}
@list l51:level5
	{mso-level-text:%5;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l51:level6
	{mso-level-text:%6;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l51:level7
	{mso-level-text:%7;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l51:level8
	{mso-level-text:%8;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l51:level9
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l52
	{mso-list-id:1812552560;
	mso-list-type:hybrid;
	mso-list-template-ids:654737176 67698693 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l52:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l53
	{mso-list-id:1816682448;
	mso-list-template-ids:-784801062;}
@list l53:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l53:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l53:level3
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-text:"%3\)";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l53:level4
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-text:"\(%4\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l53:level5
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l53:level6
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l53:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l53:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l53:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l54
	{mso-list-id:1835493229;
	mso-list-type:hybrid;
	mso-list-template-ids:1963475592 -162918348 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l54:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.6in;
	mso-level-number-position:left;
	text-indent:-18.25pt;
	font-family:Wingdings;}
@list l55
	{mso-list-id:1860773060;
	mso-list-type:simple;
	mso-list-template-ids:1515980402;}
@list l55:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-weight:bold;}
@list l56
	{mso-list-id:1866015795;
	mso-list-type:hybrid;
	mso-list-template-ids:-719415976 67698693 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l56:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l57
	{mso-list-id:1869180514;
	mso-list-template-ids:-1483452776;}
@list l57:level1
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%1\)";
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l57:level2
	{mso-level-number-format:alpha-lower;
	mso-level-text:"\(%2\)";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l57:level3
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%3\)";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l57:level4
	{mso-level-text:"\(%4\)";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l57:level5
	{mso-level-number-format:alpha-lower;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l57:level6
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l57:level7
	{mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l57:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l57:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l58
	{mso-list-id:1978678049;
	mso-list-type:hybrid;
	mso-list-template-ids:1411676554 67698693 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l58:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l59
	{mso-list-id:2059817004;
	mso-list-template-ids:-1213419456;}
@list l59:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l59:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l59:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l59:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l59:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l59:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l59:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l59:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l59:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l60
	{mso-list-id:2077392087;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l60:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
ol
	{ul
	{-->
</style>
</head>
<body bgcolor="#FFFFFF" style='tab-interval:.5in' lang=EN-CA>
<div class=Section1> 
  <h5>DATE:<span style="mso-spacerun: yes">  </span>20050613<br>
    <b style='mso-bidi-font-weight:
normal'>DOCKET: C39408</b></h5>
  <h2 style='line-height:normal'>COURT OF APPEAL FOR ONTARIO</h2>
  <h4 align=center style='text-align:center;line-height:normal'><span
lang=EN-US>SIMMONS AND GILLESE JJ.A. AND HENNESSY J. (<i>AD HOC</i>)</span></h4>
  <table border=0 align="center" cellpadding=0 cellspacing=0 style='border-collapse:collapse;
 mso-padding-alt:0in 5.4pt 0in 5.4pt'>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>B E T W E E 
          N:</b></p></td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>NANCY GAIL ARMSTRONG, 
          DAVID ARMSTRONG, SCOTT BRUCE </b><b style='mso-bidi-font-weight:normal'>ARMSTRONG, 
          CONNIE JUNE </b><b style='mso-bidi-font-weight:normal'>ARMSTRONG-KRUGER, 
          DIANNE </b><b style='mso-bidi-font-weight:normal'>BOUDREAU, FREDRICK 
          COWPER AND JUNE COWPER<br>
          Plaintiffs/Respondents </b></p></td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>Kirk F. Stevens<br>
          </b><b style='mso-bidi-font-weight:normal'>and Brian T. Butler<br>
          </b><b style='mso-bidi-font-weight:normal'>for the appellants Dr. Caroline 
          Huh and Dr. J.E. Sheriton</b></p></td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>- and -</b></p></td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoBodyText>CENTENARY HEALTH CENTRE, DR. ESHRAT SAYANI, DR. PETER 
          WALKOVICH, DR. ARNOLD <b style='mso-bidi-font-weight:normal'>TEPPERMAN, 
          DR. MICHAEL </b><b style='mso-bidi-font-weight:normal'>SANDERS, DR. 
          MICHAEL B. </b><b style='mso-bidi-font-weight:normal'>WILTON, <u>DR. 
          CAROLINE HUH</u>, </b><b style='mso-bidi-font-weight:normal'>AND <u>DR. 
          J.E. SHERITON<br>
          </u>Defendants/Appellants<u> </u></b></p></td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>Morton Greenglass, 
          Q.C.<br>
          </b><b style='mso-bidi-font-weight:normal'>for the respondents</b></p></td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td colspan="2" valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>Heard:<span
  style="mso-spacerun: yes">  </span>October 14, 2004</b></p></td>
    </tr>
  </table>
  <p class=MsoBodyText><span style='mso-bidi-font-weight:bold'>On appeal from 
    the judgment of Justice Lloyd Brennan of the Superior Court of Justice dated 
    December 20, 2002 reported at [2002] O.J. No. 5011.</span></p>
  <h4 style='line-height:normal'><span lang=EN-US>SIMMONS J.A.:</span></h4>
  <h3 style='mso-list:l45 level1 lfo74;
'> <span lang=EN-US style='mso-ansi-language:
EN-US;mso-bidi-font-weight:bold'>I.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> <span lang=EN-US style='mso-ansi-language:EN-US;
mso-bidi-font-weight:bold'>Overview</span></h3>
  <p class=MsoNormal><b><span lang=EN-US
style='mso-ansi-language:EN-US'>i) the Facts</span></b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [1]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In June 1999, Nancy Armstrong was diagnosed with an advanced stage 
    of clear cell ovarian cancer. Tragically, she succumbed to this deadly disease 
    in September 2003 at the age of 53. Prior to her death, Mrs. Armstrong and 
    her family commenced these proceedings, claiming that several doctors who 
    treated her for abdominal pain in 1998 at Centenary Health Centre failed to 
    diagnose ovarian cancer when they ought to have done so. The issues on appeal 
    concern whether the trial judge erred in finding the appellants, Dr. Caroline 
    Huh and Dr. Jack Sheriton, liable for damages arising from Mrs. Armstrong's 
    premature death. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [2]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Huh is a gynaecologist who saw Mrs. Armstrong on three occasions 
    between June and August 1998. Dr. Huh formed a clinical impression that Mrs. 
    Armstrong had chronic pelvic inflammatory disease with secondary adhesions 
    in the pelvis, meaning that organs or tissues have become stuck to each other 
    as the result of the formation of scar tissue. On the last occasion that she 
    saw Mrs. Armstrong, Dr. Huh ordered an ultrasound and made a note that a diagnostic 
    laparoscopy would be required if the ultrasound was abnormal.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [3]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Following the ultrasound and while Dr. Huh was on vacation, Mrs. Armstrong 
    consulted Dr. Sheriton, another gynaecologist. On September 1, 1998, Dr. Sheriton 
    performed a diagnostic laparoscopy. During the course of this procedure, Dr. 
    Sheriton called in a general surgeon, Dr. Mohan, to assist in dividing numerous 
    adhesions that Dr. Sheriton observed in Mrs. Armstrongs pelvis. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [4]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Sheriton testified that he believed that Mrs. Armstrong's pain 
    was caused by adhesions related to a prior pelvic inflammatory disease. He 
    said that adhesions are a common cause of pelvic pain and that once they have 
    been divided it is not unusual that the patient's symptoms are cured. When 
    asked if the disease that caused the symptoms is also cured, Dr. Sheriton 
    responded, There was no disease to be found. Once the adhesions [were] lysed, 
    the pelvic organs looked normal.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [5]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> At trial, Mrs. Armstrong relied on the expert evidence of Dr. Ralph 
    Hodd, the gynaecologist who diagnosed her cancer in June of 1999. Dr. Hodd 
    explained that pelvic inflammatory disease can be either acute, meaning it 
    is the result of a recent infection; or chronic, meaning the infection is 
    gone but the inflammation remains. However, Dr. Hodd stated that, in his opinion, 
    pelvic inflammatory disease did not fit with what he discovered in Mrs. Armstrong's 
    pelvis when he operated in 1999. Rather, he opined that Drs. Huh and Sheriton 
    were both negligent in failing to detect Mrs. Armstrong's cancer and that 
    if Mrs. Armstrongs cancer had been detected sooner, the diagnosis quite probably 
    would have saved her life. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [6]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Hodd explained that the stage and sub-stage at which ovarian cancer 
    is discovered are significant to the prognosis for survival. In stage I ovarian 
    cancer, the growth of malignant cells is confined to the ovaries; whereas, 
    in stages II, III, and IV ovarian cancer, malignant cells have spread from 
    the ovaries to other pelvic tissues, to the abdomen, or to more distant areas 
    of the body, respectively. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [7]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Further, while sub-stages I a and b ovarian cancer indicate that the 
    ovary capsules are still intact and that cancer is confined to one (stage 
    I a) or both (stage I b) ovaries, in sub-stage I c ovarian cancer:</p>
  <p class=headingNUMBER style='line-height:
normal;mso-list:l35 level1 lfo104;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> there is tumour on the surface of one or both ovaries; or<span style="mso-spacerun: yes">  
    </span></p>
  <p class=headingNUMBER style='line-height:
normal;mso-list:l35 level1 lfo104;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> the ovary capsule has ruptured; or </p>
  <p class=headingNUMBER style='line-height:
normal;mso-list:l35 level1 lfo104;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> there are ascites<a style='mso-footnote-id:ftn1'
href="#_ftn1" name="_ftnref1" title=""><span class=MsoFootnoteReference><span
style='mso-special-character:footnote'> [1] </span></span></a> present containing 
    malignant cells or positive peritoneal washings<a
style='mso-footnote-id:ftn2' href="#_ftn2" name="_ftnref2" title=""><span
class=MsoFootnoteReference><span style='mso-special-character:footnote'> [2] </span></span></a>. 
  </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [8]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Hodd testified that in June 1999 pathology confirmed that Mrs. 
    Armstrongs cancer had progressed to stage III b. In Dr. Hodds view, as of 
    May 1998, Mrs. Armstrong had at least stage I c, and possibly stage II c, 
    ovarian cancer. In addition, he opined that Drs. Sheriton and Mohan likely 
    failed to observe a tumour on the surface of Mrs. Armstrong's ovaries during 
    the diagnostic laparoscopy performed on September 1, 1998.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [9]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Following completion of the evidence at trial, the respondents amended 
    their statement of claim to advance an alternative claim that Dr. Sheriton 
    was negligent in failing to perform a hysterectomy as a remedy for chronic 
    pelvic inflammatory disease. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [10]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The appellants position at trial was that Mrs. Armstrong did not 
    have detectable ovarian cancer while under their care; in the alternative, 
    if Mrs. Armstrong did have detectable ovarian cancer, the appellants claimed 
    that it must have progressed to a point that her prospects for survival were 
    less than 50%.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b><span
style='mso-tab-count:1'>            </span>ii) the trial judges findings</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [11]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In addition to Drs. Huh and Sheriton, the action proceeded to trial 
    against Dr. Peter Walkovich, a general surgeon who performed an emergency 
    appendectomy on Mrs. Armstrong on May 8, 1998. On December 20, 2002, Brennan 
    J. dismissed the claim against Dr. Walkovich but granted judgment against 
    the appellants. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [12]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The trial judge gave extensive reasons and made numerous findings 
    of fact. The appellants grounds of appeal relate, in part, to the reasonableness 
    of the trial judges findings. I will highlight the portions of the trial 
    judges reasons that are of particular significance to the issues on appeal.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [13]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In relation to the standard of care issue, the trial judges findings 
    include the following:</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><span
style='mso-tab-count:1'>            </span><b>(a) as against Dr. Huh</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l12 level1 lfo77;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> by July 27, 1998, laboratory tests<a style='mso-footnote-id:
ftn3' href="#_ftn3" name="_ftnref3" title=""><span class=MsoFootnoteReference><span
style='mso-special-character:footnote'> [3] </span></span></a> ordered by Dr. 
    Huh had all proved negative for active infection and had therefore demonstrated 
    that there was no active infectious process to explain the inflammation and 
    adhesions in Mrs. Armstrong's pelvis, that is, no pelvic inflammatory disease 
    in the sense in which the term is generally understood; </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l12 level1 lfo77;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> while pelvic inflammatory disease may have been a reasonable 
    working diagnosis until the negative laboratory test results were known, thereafter, 
    it was no longer reasonable for Dr. Huh to maintain pelvic inflammatory disease 
    as her primary diagnosis; </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l12 level1 lfo77;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Dr. Huh had a duty to review and revise her working diagnosis 
    and failed to do so; and</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l12 level1 lfo77;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> a proper differential diagnosis would have included cancer 
    as a possible source of the inflammation known to be present in Mrs. Armstrong's 
    pelvis. </p>
  <p class=headingNUMBER style='line-height:normal;mso-list:
none;'><b>(b) as against Dr. Sheriton</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l12 level1 lfo77;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Dr. Sheriton's diagnostic laparoscopy demonstrated that Mrs. 
    Armstrong did not have pelvic inflammatory disease; and</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l12 level1 lfo77;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> once pelvic inflammatory disease was ruled out, Dr. Sheriton 
    had a duty to investigate the cause of the inflammation and adhesions in Mrs. 
    Armstrong's pelvis either through laboratory analysis of tissue or fluid samples 
    or of washings taken at the time of surgery, or by returning to the process 
    of diagnosis following surgery, and he failed to do so. </p>
  <p class=headingNUMBER style='line-height:normal;mso-list:
none;'><b>(c) as against both Drs. Huh and Sheriton</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l12 level1 lfo77;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Mrs. Armstrong had stage I clear cell ovarian cancer while 
    under the care of Drs. Huh and Sheriton; </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l12 level1 lfo77;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> if Dr. Hodd's view is correct, the possibility of early stage 
    cancer as the source of the inflammation ought to have been considered;<span
class=MsoFootnoteReference> </span></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l12 level1 lfo77;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> it is probable that the inflammation that was causing Mrs. 
    Armstrong's pain and distress was also causing the continuing development 
    of the adhesions;</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l12 level1 lfo77;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Dr. Mohans surgical report was the only record that Mrs. Armstrongs 
    ovaries and fallopian tubes were rendered visible, but [t]hat they appeared 
    healthy to him, a general surgeon, is not  diagnostic;</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l12 level1 lfo77;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> all other probable causes of her continuing inflammation had 
    been excluded on clinical grounds; and </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l12 level1 lfo77;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> the appellants failed in their duty to use reasonable means 
    to detect Mrs. Armstrong's cancer.<a style='mso-footnote-id:ftn4'
href="#_ftn4" name="_ftnref4" title=""><span class=MsoFootnoteReference><span
style='mso-special-character:footnote'> [4] </span></span></a><span
style="mso-spacerun: yes">  </span></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [14]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In relation to causation, the trial judge found that the survival 
    rate exceeds 50% for patients diagnosed with stage I ovarian cancer and that 
    Mrs Armstrongs life expectancy would have been substantially enhanced if 
    her cancer had been detected sooner. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [15]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Relying on <i style='mso-bidi-font-style:normal'>Snell v. Farrell</i>,<i style='mso-bidi-font-style:normal'> 
    </i>[1990] 2 S.C.R. 311, for the principle that causation need not be established 
    with scientific precision, the trial judge concluded that Drs. Huh and Sheriton 
    were liable for the damages suffered by the respondents and granted judgment 
    against the appellants in the amount of $972,558.34, being the damages arising 
    from Mrs. Armstrongs anticipated premature death.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [16]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> With respect to the respondents alternative claim that Dr. Sheriton 
    ought to have performed a hysterectomy as a remedy for pelvic inflammatory 
    disease, the trial judge accepted Dr. Sheriton's evidence that, once the adhesions 
    were lysed, Mrs. Armstrong's pelvic organs looked normal. The trial judge 
    said,<span style="mso-spacerun: yes">  </span>Dr. Sheriton was under no duty 
    to excise organs he thought were healthy. </p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b><span
style='mso-tab-count:1'>            </span>iii) issues on appeal</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [17]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The dispositive issues on appeal that I will address in detail are 
    the following: </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> 1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> <span style="mso-spacerun: yes"> </span>Is the trial judges finding 
    unreasonable that Mrs. Armstrong had detectable stage I clear cell ovarian 
    cancer while under the appellants care? </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> 2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> <span style="mso-spacerun: yes"> </span>If Mrs. Armstrong did have 
    detectable stage I clear cell ovarian cancer while under the appellants care, 
    is the trial judges finding unreasonable that the survival rate exceeds 50% 
    for patients diagnosed with stage I ovarian cancer?</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> 3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> With respect to the finding of liability against Dr. Huh, did the 
    trial judge err by ignoring evidence that Mrs. Armstrong did not return to 
    see Dr. Huh following an ultrasound she ordered in early August 1998?</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:
none;'><b>iv) brief statement of my conclusion</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [18]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The third ground of appeal is a complete answer to the respondents 
    claim against Dr. Huh. For reasons that I will explain, I am satisfied that 
    it establishes a break in the chain of causation. Accordingly, based on the 
    third ground of appeal, I would set aside the judgment against Dr. Huh and 
    dismiss the respondents claim against her. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [19]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> As for the first and second grounds of appeal (which relate to both 
    Dr. Huh and Dr. Sheriton), I agree that the trial judge made errors in his 
    findings requiring a new trial, but I reject the appellants submissions that 
    they justify an order dismissing the respondents claim. As I have already 
    disposed of the claim against Dr. Huh, based on the first and second grounds 
    of appeal, I would set aside the judgment against Dr. Sheriton and order a 
    new trial of the respondents claim against him.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b>II. Background</b></p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b><span
style='mso-tab-count:1'>            </span>i) 1998 treatment of Mrs. Armstrong</b></p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b><span
style='mso-tab-count:1'>            </span><span style='mso-tab-count:1'>            
    </span>a) introduction</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [20]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Hodd testified that the vast majority of ovarian cancers are discovered 
    through bi-manual pelvic examination, ultrasound, or direct examination of 
    the ovaries and pelvis, and that, of the three, the latter is the best method 
    of detection. Between March 1998 and September 1998, Mrs. Armstrong consulted 
    several physicians, underwent three bi-manual pelvic examinations, three ultrasound 
    examinations, and had two surgeries because of abdominal pain. However, throughout 
    this period, none of her physicians considered ovarian cancer as a possible 
    cause of her symptoms. </p>
  <p class=headingNUMBER align=left style='text-align:left;line-height:normal;
mso-list:none'><b><span style='mso-tab-count:1'>            </span><span
style='mso-tab-count:1'>            </span>b) the May 7, 1998 ultrasound</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [21]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In March 1998, Mrs. Armstrong consulted Dr. Sayani (a doctor she consulted 
    from time to time but not her regular family doctor). Dr. Sayani performed 
    a bi-manual pelvic examination and noted that the results were normal. In 
    addition, Dr. Sayani ordered a barium enema and prescribed an antibiotic for 
    diverticulitis. When the pain did not subside, Mrs. Armstrong's family doctor 
    referred her to Dr. Sanders, a gastroenterologist. Dr. Sanders ordered an 
    ultrasound examination, which took place on May 7, 1998. As a result of the 
    ultrasound findings, Dr. Sanders referred Mrs. Armstrong to Dr. Walkovich 
    for an emergency appendectomy on May 8, 1998.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [22]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Walkovich testified that the May 7, 1998 ultrasound report indicated 
    fluid<a style='mso-footnote-id:ftn5' href="#_ftn5" name="_ftnref5"
title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [5] </span></span></a> between loops of bowel in the lower right quadrant 
    of the abdomen; a thickened appendix; normal uterus, ovaries, and fallopian 
    tubes; and no fluid in the pelvis. </p>
  <p class=headingNUMBER align=left style='text-align:left;line-height:normal;
mso-list:none'><span style='mso-tab-count:1'>            </span><span
style='mso-tab-count:1'>            </span><b style='mso-bidi-font-weight:normal'>c) 
    the May 8, 1998 appendectomy</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [23]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> During the May 8, 1998 appendectomy, Dr. Walkovich found a moderate 
    amount of fluid in the abdomen (indicating inflammation), and noticed inflammation 
    on the surface of the appendix and in the lower right quadrant of the abdomen. 
    He also observed abdominal adhesions. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [24]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Walkovich was unable to say when the adhesions developed. He explained 
    that adhesions can be the result of a number of different things, including 
    previous abdominal surgery, a minor infection of the abdominal organs, or 
    a minor trauma of some sort. However, because he divided the abdominal adhesions 
    by passing his hand between the abdominal wall and the omentum (an apron of 
    fat that covers the inside layer of the abdominal wall), he suspected that 
    those adhesions had not been present for years and years. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [25]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Walkovich also saw considerable adhesions in Mrs. Armstrong's 
    pelvis. While he confirmed that Mrs. Armstrongs adhesions were light in some 
    areas, he said they were rather dense in others. When Dr. Walkovich explored 
    the left side of Mrs. Armstrong's pelvis, he encountered what felt like a 
    sausage-like mass measuring about six to seven centimetres long and about 
    two to three centimetres in diameter. He did not suspect the mass was related 
    to ovarian cancer, because the ultrasound showed her pelvic organs were normal. 
  </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [26]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In cross-examination, Dr. Walkovich explained that a surgeon can see 
    the seeding of metastatic cancer in the abdomen with the naked eye, and 
    said that he did not encounter anything like that during Mrs. Armstrong's 
    surgery.</p>
  <p class=headingNUMBER align=left style='text-align:left;line-height:normal;
mso-list:none'><span style='mso-tab-count:1'>            </span><span
style='mso-tab-count:1'>            </span><b style='mso-bidi-font-weight:normal'>d) 
    Dr. Walkovich's clinical impression </b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [27]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In a post-operative note, Dr. Walkovich expressed his clinical impression 
    that Mrs. Armstrong's pelvic inflammation was the result of mild pelvic inflammatory 
    disease or recurrent appendicitis. He explained that he used the term mild 
    pelvic inflammatory disease because he did not encounter the big abscesses 
    seen in chronic pelvic inflammatory disease. Dr. Walkovich testified that 
    about 80-90 percent of pelvic inflammatory disease results from sexual transmission, 
    but some cases are the result of other internal infections. </p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><span
style='mso-tab-count:1'>            </span><span style='mso-tab-count:1'>            
    </span><b
style='mso-bidi-font-weight:normal'>e) the pathologist's report relating to the 
    appendectomy</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [28]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The pathologist's report dated May 12, 1998 indicated that Mrs. Armstrong 
    had periappendicitis, <i style='mso-bidi-font-style:normal'>i.e.</i>, an inflammation 
    on the surface of the appendix, rather than acute appendicitis.<a
style='mso-footnote-id:ftn6' href="#_ftn6" name="_ftnref6" title=""><span
class=MsoFootnoteReference><span style='mso-special-character:footnote'> [6] </span></span></a> 
    The pathologist suggested, [T]he possibility of a chronic smouldering infection 
    external to the appendix such as in pelvic inflammatory disease should be 
    excluded on clinical grounds.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><span
style='mso-tab-count:1'>            </span><span style='mso-tab-count:1'>            
    </span><b
style='mso-bidi-font-weight:normal'>f) the May 28, 1998 ultrasound and referral 
    to Dr. Huh</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [29]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Based on his clinical impression that she was suffering from pelvic 
    inflammatory disease, Dr. Walkovich recommended that Mrs. Armstrong have a 
    further ultrasound and referred her to Dr. Huh. The ultrasound was performed 
    on May 28, 1998. The radiologist's report includes the following comments: 
    [U]terus, ovaries and adnexae [fallopian tubes] are normal in size and echogenicity.<a style='mso-footnote-id:ftn7' href="#_ftn7" name="_ftnref7"
title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [7] </span></span></a> There is no evidence of any abnormal [fluid] 
    collection... involving the lower right quadrant... [or] free fluid in the 
    pelvis.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [30]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> On June 4, 1998, Mrs. Armstrong returned to Dr. Walkovich's office 
    reporting abdominal pain. Although Mrs. Armstrong had an appointment scheduled 
    with Dr. Huh in July, Dr. Walkovich arranged for Dr. Huh to see her in the 
    emergency department of Scarborough Centenary Hospital on June 9, 1998.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none;'><b
style='mso-bidi-font-weight:normal'><span style='mso-tab-count:2'>                      
    </span><span
style='mso-tab-count:1'>            </span>g) the June 9, 1998 appointment with 
    Dr. Huh</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [31]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Huh testified that she reviewed Dr. Walkovich's post-operative 
    note prior to meeting with Mrs. Armstrong on June 9, 1998. Because Dr. Walkovich's 
    findings were compatible with chronic pelvic inflammatory disease and because 
    the ultrasound results did not indicated any abnormalities in Mrs. Armstrong's 
    ovaries, Dr. Huh did not consider the possibility of cancer. Dr. Huh explained 
    that ultrasound can pick up items as small as three to four millimetres and 
    that it is very sensitive in picking up small changes in the ovaries. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [32]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In her meeting with Mrs. Armstrong, Dr. Huh took a history and carried 
    out abdominal and pelvic examinations. During the pelvic examination, Dr. 
    Huh did not palpate any masses or enlarged ovaries but found that Mrs. Armstrong's 
    uterus and cervix were tender. She interpreted the tenderness as a sign of 
    inflammation and therefore took cervical swabs to test for gonorrhea and chlamydia. 
    Dr. Huh said that she formed a clinical impression that Mrs. Armstrong had 
    chronic pelvic inflammatory disease with secondary adhesions in the pelvis. 
  </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [33]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Huh described chronic pelvic inflammatory disease as involving 
    findings of adhesions in ... somebody complaining of pain usually with a history 
    of prior infection in the pelvis.<span style='mso-bidi-font-style:
italic'></span> She explained that the prior infection may have been many years 
    before, that it may have caused inflammation leading to adhesions, and that, 
    if damaged by inflammation, the fallopian tubes become more susceptible to 
    reinfection. Dr. Huh also noted that the prior infection may have been sub-clinical 
    <i style='mso-bidi-font-style:normal'>i.e</i>., the patient may not have known 
    about it. Unlike Dr. Hodd, Dr. Huh appeared to imply that inflammation recurs 
    as an element of the disease only when there is reinfection. However, she 
    clarified that sexually transmitted disease need not be the source of reinfection; 
    it can be caused, for example, by bacteria from adjacent organs. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [34]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> When asked about the treatment for chronic pelvic inflammatory disease, 
    Dr. Huh said that it depends on the symptoms. She explained that one of the 
    reasons for pain is reinfection of the tissues in which case the treatment 
    may be with antibiotics. Another reason for pain can be adhesions in the pelvis, 
    requiring surgical treatment to remove the adhesions. Lastly, if those other 
    measures are not helpful, it may be necessary to remove the uterus, tubes 
    and ovaries. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [35]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In Mrs. Armstrong's case, although Dr. Huh found tenderness, she felt 
    it was not marked tenderness. Accordingly, Dr. Huh began with two broad-spectrum 
    antibiotics, the least radical treatment.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [36]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In cross-examination, Dr. Huh explained that chronic pelvic inflammatory 
    disease was her working diagnosis <i style='mso-bidi-font-style:
normal'>i.e.</i>, the most likely of a long list of differential diagnoses. Because 
    she found no suspicious mass and her other findings were inconsistent with 
    cancer, she did not consider ovarian cancer as part of her differential diagnosis. 
  </p>
  <p class=headingNUMBER align=left style='text-align:left;line-height:normal;
mso-list:none'><span style='mso-tab-count:1'>            </span><span
style='mso-tab-count:1'>            </span><b style='mso-bidi-font-weight:normal'>h) 
    the July 10, 1998 appointment with Dr. Huh</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [37]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> On July 10, 1998, Mrs. Armstrong reported to Dr. Huh that she had 
    finished the antibiotics and had very little pain. Dr. Huh informed Mrs. Armstrong 
    that the tests performed on June 9, 1998 were negative. However, as a matter 
    of precaution, Dr. Huh ordered additional tests for HIV and syphilis. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [38]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Huhs note of the July 10, 1998 visit confirms that her clinical 
    impression was chronic pelvic inflammatory disease. Dr. Huh said that she 
    booked a further appointment with Mrs. Armstrong for August 6, 1998 because 
    she wanted to follow-up and make sure that Mrs. Armstrong was symptom-free. 
  </p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><span
style='mso-tab-count:1'>            </span><span style='mso-tab-count:1'>            
    </span><b
style='mso-bidi-font-weight:normal'>i) the August 6, 1998 appointment with Dr. 
    Huh</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [39]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> On August 6, 1998, Mrs. Armstrong reported having had an episode of 
    abdominal pain the week before, along with fever, constipation and upper respiratory 
    symptoms. Although it was her impression that the pain episode was not related 
    to chronic pelvic inflammatory disease, Dr. Huh ordered a further ultrasound 
    to check for evidence of ongoing inflammation. According to Dr. Huh, she also 
    discussed with Mrs. Armstrong the possibility of diagnostic laparoscopy to 
    confirm the presence of chronic pelvic inflammatory disease, to assess the 
    severity of the adhesions, and potentially also to remove adhesions. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [40]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Huh made the following note of the August 6, 1998 appointment 
    in Mrs. Armstrong's chart, [I]mpression -- not likely related to chronic 
    PID. Plan: ultrasound to rule out hydrosalpinx [a blocked, fluid-filled fallopian 
    tube] and will need laparoscopy if ultrasound is abnormal. </p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><span
style='mso-tab-count:1'>            </span><span style='mso-tab-count:1'>            
    </span><b
style='mso-bidi-font-weight:normal'>j) the August 14, 1998 ultrasound</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [41]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The sonographers report and the radiologists report of the August 
    14, 1998 ultrasound both indicated the likelihood of chronic pelvic inflammatory 
    disease and fluid in the Pouch of Douglas (a crease behind the ovaries). In 
    addition, the radiologist's report noted, This collection is more than on 
    our last examination of May 7, 1998 indicative of a hydrosalpinx. </p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b
style='mso-bidi-font-weight:normal'><span style='mso-tab-count:1'>            
    </span><span
style='mso-tab-count:1'>            </span>k) no further appointments with Dr. 
    Huh after August 6, 1998</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [42]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Huh was on holiday from August 15 until August 24, 1998. While 
    Dr. Huh was away, Mrs. Armstrong consulted her family doctor, Dr. Schunk. 
    Dr. Schunk referred Mrs. Armstrong to Dr. Sheriton. Dr. Sheriton saw Mrs. 
    Armstrong in his office on August 19, 1998. After seeing Mrs. Armstrong, he 
    scheduled her for a diagnostic laparoscopy, which he eventually performed 
    on September 1, 1998.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [43]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Huh received the radiologists report of the August 14, 1998 ultrasound 
    but did not see Mrs. Armstrong after their August 6, 1998 appointment. Dr. 
    Huh testified that she anticipated seeing Mrs. Armstrong following the ultrasound 
    to review the results and, if necessary, to make recommendations for further 
    treatment. However, when she returned from her holiday, her secretary informed 
    her that Mrs. Armstrong had called to say that she had seen another gynaecologist 
    and was scheduled for surgery.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [44]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Contrary to Dr. Huh's evidence, Mrs. Armstrong testified that after 
    seeing Dr. Sheriton she spoke to Dr. Huh directly and Dr. Huh agreed to attend 
    the laparoscopy. According to Mrs. Armstrong, she consulted Dr. Schunk because 
    Dr. Huh refused to operate. However, because she (Mrs. Armstrong) did not 
    know Dr. Sheriton, she asked Dr. Huh to attend the laparoscopy for moral support. 
    Mrs. Armstrong testified initially that Dr. Huh told her that she would gladly 
    assist Dr. Sheriton. Subsequently, in response to questions from the trial 
    judge, Mrs. Armstrong conceded that she could not swear that Dr. Huh used 
    the word assist. Mr. Armstrong also said that she did not learn that Dr. 
    Huh did not attend the laparoscopy until after she was diagnosed with cancer.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b
style='mso-bidi-font-weight:normal'><span style='mso-tab-count:1'>            
    </span><span
style='mso-tab-count:1'>            </span>l) the September 1, 1998 laparoscopy</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [45]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> As already noted, Dr. Sheriton saw Mrs. Armstrong in his office on 
    August 19, 1998. In addition to Dr. Schunk's referring note, Dr. Sheriton 
    had a copy of the sonographers report of the August 14, 1998 ultrasound. 
    According to Dr. Sheriton, he told Mrs. Armstrong he was planning to do a 
    diagnostic laparoscopy to determine the cause of her symptoms and that he 
    would perform a hysterectomy if he found severe pelvic inflammatory disease. 
    By severe pelvic inflammatory disease, he meant a situation where the pelvic 
    organs were matted together and could not be dissected or if there were other 
    problems such as fibroids or endometriosis. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [46]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> During the laparoscopy, which was performed on September 1, 1998, 
    Dr. Sheriton found considerable adhesions in Mrs. Armstrong's pelvis, involving 
    the fallopian tubes as well as the large bowel. Because he is not an expert 
    in bowel surgery, Dr. Sheriton called in Dr. Mohan, a general surgeon, to 
    assist in dividing the adhesions. Dr. Sheriton testified that he operated 
    the magnifying video camera while Dr. Mohan did the dissections. He said that 
    once the adhesions were freed, they were able to see the ovaries and the fallopian 
    tubes through the camera, and that both looked normal. Dr. Sheriton explained 
    that one has to flip the ovaries one way and then the other in order to divide 
    all of the adhesions. Accordingly, the doctors looked at the entire surface 
    of the ovaries on both sides. Dr. Sheriton said he did not find evidence of 
    a hydrosalpinx, or of a mass, or of anything else suggestive of ovarian cancer. 
    He testified that he did not perform a hysterectomy because once the adhesions 
    were freed and he could see that the pelvic organs looked normal, there was 
    no indication to do so. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [47]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Sheriton saw Mrs. Armstrong at follow-up visits on September 15, 
    1998 and November 15, 1998. He testified that he found no abnormalities on 
    examination and concluded that the surgery had been successful. He said that 
    he would have told Mrs. Armstrong that if she had any further problems to 
    contact him or her family doctor.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b
style='mso-bidi-font-weight:normal'><span style='mso-tab-count:1'>            
    </span>ii) Dr. Mohan's evidence at trial </b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [48]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Mohan confirmed that he was called in to assist during Mrs. Armstrong's 
    laparoscopy because Dr. Sheriton encountered dense adhesions and wanted help 
    mobilizing the bowel so that he could observe the pelvic organs properly. 
    Dr. Mohan said he had no independent recollection of the surgery and was relying 
    on his operative notes in giving evidence.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [49]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Mohan testified that he and Dr. Sheriton were able to see the 
    right fallopian tube and ovary once the adhesions on the right side of the 
    pelvis were removed. On the left side, those organs were not readily visible 
    until he mobilized the sigmoid colon. Dr. Mohan explained that the process 
    of freeing up the adhesions allows you to see both sides of the ovary. His 
    notes indicated that both ovaries appeared healthy, meaning that he did not 
    see evidence of abnormal enlargement, unusually large cysts, endometriosis, 
    growths or excrescenses on the surface of either ovary.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [50]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> When asked in cross-examination if he observed whether Mrs. Armstrong 
    had pelvic inflammatory disease, Dr. Mohan said he saw adhesions and scar 
    tissue in the pelvis, which could be a sequela of pelvic inflammatory disease. 
    He speculated that the adhesions were caused either by previous surgery or 
    previous infection and explained that sexually transmitted diseases are not 
    the only infections that cause adhesions. Dr. Mohan testified that it would 
    be difficult to determine the cause of the adhesions because the cause may 
    be very remote; there is no temporal relationship between the presentation 
    of symptoms from adhesions and the inciting episode.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b
style='mso-bidi-font-weight:normal'><span style='mso-tab-count:1'>            
    </span>iii) the expert evidence at trial</b></p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b
style='mso-bidi-font-weight:normal'><span style='mso-tab-count:1'>            
    </span><span
style="mso-spacerun: yes">  </span>a) the respondents evidence</b></p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b
style='mso-bidi-font-weight:normal'><span style='mso-tab-count:1'>            
    </span><span
style='mso-tab-count:1'>            </span>A) Dr. Hodd</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [51]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Hodd was permitted to give evidence as Mrs. Armstrong's treating 
    physician and to express his opinion concerning her previous care and about 
    matters relating to the surgical and oncological care of gynaecology patients 
    in general. He acknowledged that he had only encountered two cases of clear 
    cell ovarian cancer in his career and also agreed that the prospects of survival 
    associated with ovarian cancer were not within his area of expertise. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [52]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Hodd first met Mrs. Armstrong on June 14, 1999 and operated on 
    her on June 16, 1999. On that date, he found tumours in both of her ovaries, 
    as well as evidence of cancer in the abdomen and peritoneum. He removed her 
    ovaries and fallopian tubes, as well as the omentum, but did not remove the 
    uterus, as it was adhered densely to the bladder and fixed to the pelvis, 
    and he worried that he might not be able to control the bleeding if he excised 
    it. Following chemotherapy, he did a further operation in November of 1999 
    and removed her uterus at that time.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:
none'><b>1) Dr. Hodds evidence concerning pelvic inflammatory disease</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [53]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Hodd explained that pelvic inflammatory disease generally refers 
    to inflammatory changes in the pelvis, usually infection or inflammation of 
    the fallopian tubes and ovaries. He said that chronic pelvic inflammatory 
    disease is a progressive disease, which does not stop because the infection 
    is gone. Over time, the fallopian tubes become blocked and distended, and 
    tubo-ovarian abscesses may appear. Elsewhere, Dr. Hodd explained that there 
    can be degrees of pelvic inflammatory disease and that if, for example, someone 
    has extreme pelvic infection with large tubo-ovarian abscesses, the patient 
    can become extremely ill and theoretically, can die.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [54]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Hodd testified that he did not find specific evidence of pelvic 
    inflammatory disease when he operated on Mrs. Armstrong in June of 1999, but 
    qualified that by saying that he did not find specific evidence of what [he] 
    would expect from pelvic inflammatory disease, inflamed distended fallopian 
    tubes, the usual particular findings of a lot of adhesions between tubes and 
    ovaries, etc., that there had been a lot of previous damage. Further, Dr. 
    Hodd acknowledged that it was difficult to say with precision that the adhesions 
    he observed in June of 1999 were all from inflammation due to cancer or if 
    some were due to previous disease. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [55]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> However, Dr. Hodd noted that when he performed the second operation 
    in November of 1999 following chemotherapy, everything was cleared up very 
    nicely...[t]here was no evidence of any tumour and there was no evidence of 
    any inflammatory changes either. Dr. Hodd explained that chemotherapy changes 
    what is malignant but should not eliminate the effects of pelvic inflammatory 
    disease. He noted that in November of 1999, Mrs. Armstrong's uterus was free 
    of its surrounding structures such as the bladder, and said, If that had 
    been due to pelvic inflammatory disease chemotherapy shouldn't change that. 
  </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [56]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Hodd testified,  [A]lthough I cannot say with absolute certainty 
    that she could not have had some previous infection or inflammation, it is 
    my opinion that there was not and I feel that all of the obvious inflammatory 
    changes that did occur ... [were] secondary to the presence of the cancer. 
  </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [57]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In cross-examination, Dr. Hodd acknowledged that he did not believe 
    the mass Dr. Walkovich had described was an ovarian cancer tumour. Rather, 
    he concluded that it was consistent with the adhesions associated with the 
    left ovary and fallopian tube and the omentum. </p>
  <p class=headingNUMBER style='line-height:normal;mso-list:
none'><b>2) Dr. Hodds evidence concerning ovarian cancer</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [58]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> During the course of his evidence, Dr. Hodd explained the nature of 
    Mrs. Armstrong's cancer and the staging of ovarian cancer for treatment purposes. 
    Dr. Hodd testified that 90 percent of ovarian cancers are epithelial (referring 
    to a lining) in origin. He said that Mrs. Armstrong had clear cell carcinoma, 
    a rare type of epithelial cancer accounting for five percent of all ovarian 
    cancers.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> <span
style='mso-bidi-font-style:italic'>[59]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Dr. Hodd opined that, in May of 1998, Mrs. Armstrong's cancer 
    was at least a I c, possibly as much as a II c. He thought that it was quite 
    probable that Mrs. Armstrong's tumour took more than a year, perhaps as much 
    as two years, to develop. Although he acknowledged that between September 
    of 1998 and June of 1999 Mrs. Armstrong's cancer could have progressed from 
    being undetectable to stage III b (the stage at which he discovered it), he 
    disagreed that that is what occurred. In his view, the more likely scenario 
    was that there was tumour present on one or both of Mrs. Armstrong's ovaries 
    while Mrs. Armstrong was under the appellants care and that the tumour had 
    ruptured the cortex of the ovaries, causing the formation of fluid and adhesions 
    in response to cancer. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> <span
style='mso-bidi-font-style:italic'>[60]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Moreover, Dr. Hodd was not persuaded that Drs. Sheriton and 
    Mohan had completely freed up or visualized Mrs. Armstrong's ovaries during 
    the diagnostic laparoscopy. He opined that there was likely tumour present 
    on a portion of her left ovary that they did not see. <b><span style='mso-tab-count:
1'>    </span></b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> <span
style='mso-bidi-font-style:italic'>[61]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Using the textbook <i>Clinical Gynecologic Oncology<a
style='mso-footnote-id:ftn8' href="#_ftn8" name="_ftnref8" title=""><span
class=MsoFootnoteReference><span style='mso-special-character:footnote'> [8] </span></span></a></i><span
style='mso-bidi-font-style:italic'> as his source, </span>Dr. Hodd<span
style='mso-bidi-font-style:italic'> reviewed the five-year actuarial survival 
    rates for all epithelial ovarian cancers grouped together. For stage I a, 
    the survival rate is 83.5%, for stage II c it is 61.3% and for stage III b 
    it is 29.2%. </span></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> <span
style='mso-bidi-font-style:italic'>[62]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> <span style='mso-bidi-font-style:italic'>Later in his testimony, 
    Dr. Hodd referred to an article in the March 1994 journal Obstetrics and Gynaecology 
    Clinics of North America in which the authors reported that 75% of clear cell 
    carcinomas are diagnosed in stage I, and as a result, the overall survival 
    rate for this type of cancer is 50%, much better than for other types of ovarian 
    cancer.</span></p>
  <p class=headingNUMBER align=left style='text-align:left;line-height:normal;
mso-list:none'><b><span style='mso-tab-count:1'>            </span><span
style="mso-spacerun: yes">  </span>b) the appellants' evidence</b></p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b><span
style='mso-tab-count:1'>            </span><span style='mso-tab-count:1'>            
    </span>A) Dr. Kaizer</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [63]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Kaizer has been a staff oncologist at Credit Valley hospital since 
    1985. He estimated that during that period, he has seen between 300 and 400 
    cases of ovarian cancer, about five percent of which, or 15 to 20 overall, 
    were clear cell carcinomas. He testified that, based on his personal experience 
    and his understanding of the literature, patients diagnosed with non-stage 
    I a clear cell ovarian cancer have a 0-25% chance of surviving beyond five 
    years. Moreover, in his view, the overall prognosis for clear cell ovarian 
    cancer is inferior to the prognosis for the other types of epithelial ovarian 
    cancer. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [64]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> On cross-examination, Dr. Kaizer was asked about the survival rate 
    for stage I c clear cell ovarian cancer. He responded that it is an uncommon 
    stage in an uncommon disease and that the largest series of stage I c reported 
    cases dealt with six individuals, none of whom survived beyond five years. 
  </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [65]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Kaizer opined that Mrs. Armstrong probably did not have detectable 
    cancer in 1998. He said that the cancer could have gone from undetectable 
    to detectable over a short number of months. In forming this opinion, Dr. 
    Kaizer was persuaded by the fact that none of the ultrasounds revealed evidence 
    of ovarian disease; that on direct examination of tissues, Drs. Walkovich, 
    Sheriton and Mohan did not see anything that they identified as being cancerous; 
    and that the pathology following Mrs. Armstrong's appendectomy was normal. 
  </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [66]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In response to a question from the trial judge concerning whether 
    Mrs. Armstrong may have had undetectable cancer in May 1998, Dr. Kaizer explained 
    that theoretically, it takes cancer a long time to reach the one millimetre 
    level but that once it does, it may not take long to go from that level to 
    fatal disease. He said that if Mrs. Armstrong had had microscopic cancer at 
    the one millimetre level, one would have to have been very lucky to find it, 
    even if her ovaries were removed. He said that you do not section the entire 
    ovary to look at it because you would have to make about 1,000 sections to 
    do so. </p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><span
style='mso-tab-count:1'>            </span><span style='mso-tab-count:1'>            
    </span><b>B) Dr. De Petrillo</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [67]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> At the time of trial, Dr. De Petrillo was the coordinator of the surgical 
    oncology program for Cancer Care Ontario and director of the gynaecologic 
    oncology department at the University of Toronto. Dr. De Petrillo testified 
    that during the course of his career he has dealt with about 700 cases of 
    ovarian cancer, about 40 or 50 of which were clear cell carcinoma. He said 
    that ovarian cancer is usually detected in the advanced stages when treatment 
    is not effective and also noted that the prognosis for clear cell ovarian 
    cancer is poorer than for other types of ovarian cancers.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [68]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. De Petrillo testified that based on his experience the probability 
    of survival for all stage I a epithelial ovarian cancers is 80%, but for stage 
    I clear cell carcinoma it is 63%. While the survival rate for all stage I 
    c epithelial cancers is 73%, the survival rate for stage I c clear cell carcinoma 
    is 46%. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [69]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Like Dr. Kaizer, Dr. De Petrillo opined that Mrs. Armstrong did not 
    have detectable ovarian cancer while under the appellants' care. He relied 
    on the fact that Mrs. Armstrong had had a number of ultrasounds that were 
    essentially normal and that both ovaries were described as normal after being 
    observed during a laparoscopy. He also agreed that her cancer could have progressed 
    from being undetectable to detectable over the course of six months. </p>
  <p class=headingNUMBER align=left style='text-align:left;line-height:normal;
mso-list:none'><span style='mso-tab-count:1'>            </span><span
style='mso-tab-count:1'>            </span><b>C) Dr. Owolabi</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [70]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> <span style="mso-spacerun: yes"> </span>At the time of trial, Dr. 
    Owolabi was the chief of obstetrics and gynaecology at North York General 
    Hospital. During the course of his career, he had seen about 100 to 120 cases 
    of ovarian cancer, three to four of which were clear cell carcinoma, and many 
    cases of pelvic inflammatory disease.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;'> [71]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> According to Dr. Owolabi, there are characteristics of different kinds 
    of adhesions that will indicate their origin <i>i.e</i>., tuberculosis, ovarian 
    cancer, endometriosis, or pelvic inflammatory disease. He opined that if the 
    ovaries were observed during surgery and appeared to be normal and if the 
    preceding ultrasounds revealed nothing unusual, cancer of the ovaries was 
    effectively ruled out.<a style='mso-footnote-id:ftn9' href="#_ftn9"
name="_ftnref9" title=""><span class=MsoFootnoteReference><span
style='mso-special-character:footnote'> [9] </span></span></a> </p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b>III. <span
style='mso-tab-count:1'>            </span>Analysis</b></p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b>i) Is the 
    trial judges finding unreasonable that Mrs. Armstrong had detectable stage 
    I clear cell ovarian cancer while under the appellants care?</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [72]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> According to the appellants, the trial judges conclusion that Mrs. 
    Armstrong had cancer while under the appellants care was premised on a finding 
    that cancer, and not pelvic inflammatory disease, was causing her continuing 
    inflammation and adhesions. In particular, the trial judge stated that early 
    stage cancer should have been considered as a possible source of her continuing 
    inflammation and that it was probable that the inflammation that was causing 
    Mrs. Armstrongs pain and distress, was also causing the continuing development 
    of adhesions.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [73]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The appellants submit that, contrary to the trial judges finding, 
    the only reasonable basis for finding that cancer was causing Mrs. Armstrongs 
    inflammation and adhesions was that she had a visible tumour that had ruptured 
    the cortex of her ovaries. However, since the trial judge provided no reasonable 
    basis for rejecting Dr. Mohans evidence that, on September 1, 1998, Mrs. 
    Armstrongs ovaries appeared healthy, the appellants contend that the trial 
    judges finding that Mrs. Armstrong had detectable stage I clear cell ovarian 
    cancer while under the appellants care is unreasonable, and that the respondents 
    claim should therefore be dismissed. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [74]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Subject to one caveat concerning the appellants interpretation of 
    the trial judges reasons, which I will explain later, I agree that the trial 
    judge made certain errors in his findings. However, I do not agree with the 
    appellants characterization of those errors, and I consider that it was open 
    to the trial judge to reject Dr. Mohans evidence. Accordingly, rather than 
    dismissing the respondents claim based on this ground of appeal, I would 
    order a new trial.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:
none;'><b style='mso-bidi-font-weight:normal'>a) Is the trial judges finding 
    unreasonable that early stage cancer should have been considered as a possible 
    source of Mrs. Armstrongs continuing inflammation and adhesions?</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [75]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In his reasons, the trial judge commented, If Dr. Hodds view is 
    correct, the possibility of early stage cancer as the source of the inflammation 
    ought to have been considered. To the extent that this comment leaves open 
    the possibility that stage I a or b ovarian cancer, or stage I c ovarian cancer 
    without tumour break-through, may have been causing Mrs. Armstrongs continuing 
    inflammation and adhesions, I agree that it is not supported by the evidence 
    at trial.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [76]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> As I read his evidence, Dr. Hodd testified that, in his opinion, Mrs. 
    Armstrong had at least stage I c ovarian cancer with tumour break-through, 
    and possibly as much as stage II c ovarian cancer, that it was the inflammatory 
    reaction to the tumour that caused her adhesions and that the tumour break-through 
    would be visible on laparoscopic inspection. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [77]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In particular, in response to a specific question concerning whether 
    there could be malignant cells in the abdomen <span style='color:black'>with 
    no visible break in the ovary capsule</span>, he responded, [p]robably not. 
    In response to a subsequent question about the progression of the disease, 
    Dr. Hodd confirmed that any interruption by tumour to the capsule of the ovary 
    would be visible to the naked eye. Further, when asked if it is possible that 
    adhesions could form when the cancer is fully contained within the ovary membrane, 
    he said, [n]o, not likely, because there is nothing to react to. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [78]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In addition, Dr. Hodd testified that while he could not specify an 
    exact amount of time after the onset of clear cell cancer that adhesions would 
    begin to form, certainly as soon as there is any rupture of tumour through 
    the surface of the ovary then you are going to start forming adhesions to 
    surrounding structures. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [79]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> None of the other expert witnesses offered the opinion that stage 
    I a or b, or stage I c ovarian cancer without visible tumour break-through, 
    could have been causing Mrs. Armstrongs continuing inflammation. On the contrary, 
    Dr. Kaizer effectively excluded the possibility that cancer that is contained 
    within the capsule (stage I a or b ovarian cancer) can cause inflammation. 
    Dr. De Petrillo opined that cancer at the microscopic level (which includes 
    stage I c ovarian cancer with the capsule intact but escaping fluids tainted 
    with cancer cells) does not cause inflammation. Although Dr. Owolabi allowed 
    the theoretical possibility that cancer cells in fluids escaping from an un-ruptured 
    ovary (<i>i.e.</i>, one of the forms of stage I c ovarian cancer) can cause 
    inflammation, he clarified that he did not say that they could have caused 
    the adhesions that were present in this case. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [80]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> I conclude that there was no evidence capable of supporting a finding 
    that stage I a or b clear cell ovarian cancer, or stage I c ovarian cancer 
    without tumour break-through, may have been causing Mrs. Armstrongs continuing 
    inflammation. Moreover, to the extent that the trial judges reasons leave 
    open that possibility, I conclude that his findings are in conflict with other 
    parts of his reasons.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [81]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> At para. 9 of his reasons the trial said: </p>
  <p class=headingNUMBER align=left style='
text-align:left;line-height:normal;
mso-list:none'>Clear cell carcinoma is said to be especially aggressive. One may 
    suppose that it generates ascites, with inflammation and related pain, at 
    an earlier stage. It is doubtful however that the evidence was sufficient 
    to allow me to conclude that [Mrs. Armstrongs] symptoms in 1998 were caused 
    by ascites generated by her clear cell carcinoma. </p>
  <p class=headingNUMBER align=left style='text-align:left;line-height:normal;
mso-list:none'>This appears to be a finding that the evidence was not sufficient 
    to support a conclusion that stage I c ovarian cancer without tumour break-through 
    was causing Mrs. Armstrongs symptoms. It would therefore conflict with the 
    trial judges finding that early stage cancer should have been considered 
    as a possible source of the inflammation.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [82]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> At para. 55 of his reasons, the trial judge indicated that tissue 
    samples taken from dense adhesions might well have demonstrated that Mrs. 
    Armstrong had cancer. However, if that were the case, by definition, Mrs. 
    Armstrongs cancer would have progressed beyond stage I (<i>i.e.</i>, it would 
    indicate that malignant cells had spread to other tissues). </p>
  <p class=headingNUMBER style='line-height:normal;mso-list:
none'><b>b) Did the trial judge unreasonably reject Dr. Mohans evidence that, 
    on September 1, 1998, Mrs. Armstrong's ovaries appeared healthy?</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [83]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> At para. 65 of his reasons, the trial judge referred to Dr. Mohan's 
    surgical report and, in particular, to Dr. Mohan's specific notation: [W]e 
    were able to observe both ovaries and they appear healthy. At para. 66 of 
    his reasons, the trial judge concluded, [t]his is the only record that the 
    ovaries and tubes were indeed rendered visible...[t]hat they appeared healthy 
    to him, a general surgeon, is of course not diagnostic, and Dr. Mohan had 
    no responsibility to form a gynaecological opinion.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [84]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Assuming that Mrs. Armstrong must have had a visible tumour, the appellants 
    contend that, absent an adverse credibility finding, the trial judge made 
    an unreasonable finding when he rejected Dr. Mohans evidence as not diagnostic. 
  </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [85]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> I disagree. In my view, it was open to the trial judge to reject Dr. 
    Mohan's observations as not diagnostic for a variety of reasons, including 
    the following: </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l7 level1 lfo88;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> the trial judge's own assessment of Dr. Mohan's qualifications 
    and testimony; </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l7 level1 lfo88;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> the trial judge's assessment of Dr. Hodd's competing evidence 
    that Mrs. Armstrong did not have pelvic inflammatory disease but did have 
    at least stage I c clear cell ovarian cancer with tumour break-through; and 
  </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l7 level1 lfo88;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> the facts that Dr. Mohan was not the gynaecologist in charge 
    of the procedure, was not responsible for making a gynaecological diagnosis, 
    and did not make a note of viewing the entire surface of both ovaries.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [86]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> However, while I consider that it was open to the trial judge to reject 
    Dr. Mohans evidence, I agree that the trial judges explanation for doing 
    so was insufficient. One of the major conflicts in the evidence at trial was 
    Dr. Sheritons and Dr. Mohans testimony that they observed the entire surface 
    of both of Mrs. Armstrongs ovaries and that her ovaries appeared normal as 
    compared to Dr. Hodds opinion that Mrs. Armstrong had at least stage I c 
    ovarian cancer with tumour break-through. In the face of this conflict in 
    the evidence relating to an important issue, the trial judges conclusory 
    statement that Dr. Mohans opinion was not diagnostic is not a sufficient 
    basis for resolving this issue: see <i>R. v. Sheppard</i>, [2002] 1 S.C.R. 
    869, and <i>Waxman v. Waxman</i>, [2004] O.J. No. 1765 (C.A.). </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [87]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> More importantly however, when examined in the context of the whole 
    of the trial judges reasons, in my view, it is not clear what the trial judge 
    found in relation to Dr. Sheritons and Dr. Mohans evidence. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [88]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In particular, the trial judge found that because Dr. Sheriton believed 
    Mrs. Armstrongs pelvic organs were healthy, he did not breach the standard 
    of care by failing to excise her pelvic organs on account of pelvic inflammatory 
    disease. By making this finding the trial judge at least implied that he accepted 
    Dr. Sheriton and Mohans evidence that they observed the complete surface 
    of the ovaries and that the ovaries appeared healthy. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [89]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> On the other hand, when dealing with the issue of whether the appellants 
    were negligent in failing to diagnose cancer, the trial judge made the findings 
    that Dr. Mohans surgical report was the only record indicating that Mrs. 
    Armstrongs ovaries were rendered visible and that Dr. Mohans opinion was 
    not diagnostic. The trial judge therefore discounted the evidence of both 
    Dr. Sheriton and Dr. Mohan, at least implying that he rejected it. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [90]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In my view, this apparent contradiction in the trial judges reasons 
    is sufficient on its own to justify an order for a new trial. </p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b>ii) Is the 
    trial judges finding unreasonable that the survival rate exceeds 50% for 
    patients diagnosed with stage I ovarian cancer?</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [91]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> <span style="mso-spacerun: yes"> </span>Turning to causation, the 
    trial judge made the following specific findings concerning the survival rates 
    for ovarian cancer:</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l58 level1 lfo78;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> there is some difference of opinion about the prospects of 
    survival for more than five years when clear cell ovarian cancer is detected 
    at an early stage, but there is no doubt that early detection carries better 
    prospects of successful treatment and therefore survival; </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l58 level1 lfo78;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> actuarial statistical data for all classes of ovarian cancer 
    demonstrate that the survival rate exceeds 50 % for patients diagnosed at 
    stage I<a style='mso-footnote-id:ftn10' href="#_ftn10" name="_ftnref10"
title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [10] </span></span></a>; </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l58 level1 lfo78;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> clear cell cancer is reported to have somewhat better survival 
    rates than the entire category of ovarian cancers, largely because it is more 
    often discovered at an earlier stage; and </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l58 level1 lfo78;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Mrs. Armstrong's life expectancy would have been substantially 
    enhanced if her cancer had been detected sooner. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [92]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The appellants contend that in order to find them liable the trial 
    judge was required to determine that it was more likely than not that Mrs. 
    Armstrong would have survived for more than five years if the appellants had 
    detected her cancer. Further, they submit that there was no evidence capable 
    of supporting that conclusion and that the trial judges finding was therefore 
    unreasonable. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [93]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> I agree that the issue the trial judge was required to determine was 
    whether it was more likely than not that Mrs. Armstrong would have survived 
    for more than five years if the appellants had detected her cancer. There 
    was no issue at trial that the medical standard for a cancer cure is survival 
    for five years. Moreover, the causation issue in this case is governed by 
    <i>Cottrelle et. al. v. Gerrard</i> (2003), 67 O.R. (3d) 737 (C.A.), leave 
    to appeal to S.C.C. refused, [2003] S.C.C.A. No. 549, in which this court 
    confirmed at para. 25 that it is not sufficient to prove that adequate diagnosis 
    and treatment would have afforded a chance of avoiding the unfavourable outcome 
    unless that chance surpasses the threshold of more likely than not. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [94]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> I also agree that the trial judge erred by failing to determine the 
    specific sub-stage to which Mrs. Armstrong's cancer had progressed. The trial 
    judges reasons imply that he was unable to do so. For example, the trial 
    judge commented that during the laparoscopy no fluid was collected and no 
    washings were submitted for cytology. However, as already noted, the only 
    reasonable basis for the trial judge's conclusion that cancer was causing 
    Mrs. Armstrong's continuing inflammation was that her cancer had progressed 
    to at least stage I c with tumour break-through. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [95]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> I do not accept the appellants submission that there was no evidence 
    at trial capable of supporting the trial judges finding that clear cell 
    cancer is reported to have somewhat better survival rates than the entire 
    category of ovarian cancers, largely because it is more often discovered at 
    an earlier stage. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [96]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In his testimony, Dr. Hodd referred to an article (the Clinics of 
    North America article) which set out the following conclusion:</p>
  <p class=headingNUMBER align=left style='
text-align:left;line-height:normal;
mso-list:none'>Most clear cell carcinomas (75%) are stage I disease, which is 
    why the overall survival for these tumors is 50% (much better than for serous 
    and undifferentiated carcinomas).</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [97]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The appellants submit that the 50% survival rate identified in the 
    second line of the Clinics of North America article refers to stage I clear 
    cell ovarian cancer. I disagree. In my view, read in context the 50% survival 
    rate refers to the overall survival rate for clear cell cancer. Accordingly, 
    there was an available inference that the survival rate for stage I clear 
    cell cancer is more than 50%.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [98]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> However, I agree that the trial judge erred by misapprehending or 
    ignoring the appellants' evidence concerning cancer survival rates. As already 
    noted, Dr. Kaizer testified that patients diagnosed with non-stage I a clear 
    cell ovarian cancer have a 0-25% chance of surviving beyond five years. In 
    addition, Dr. De Petrillo opined that the probability of survival for stage 
    I c clear cell ovarian cancer is 46%. Moreover, Dr. Kaizer challenged the 
    reliability of the Clinics of North America article's conclusion, noting that 
    the findings were not supported by a wealth of other literature, that the 
    study results relied on were not set out, and that the opinions expressed 
    did not distinguish between the sub-stages of stage I clear cell ovarian cancer. 
  </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [99]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Apart from noting that there is some difference of opinion about 
    the prospects of survival for more than five years when clear cell ovarian 
    cancer is detected at an early stage, the trial judge did not mention the 
    testimony of Drs. Kaizer and De Petrillo or give reasons for rejecting their 
    opinions. In my view, their evidence went farther than expressing some difference 
    of opinion; it contradicted the Clinics of North America articles conclusion, 
    upon which the trial judge relied that the overall survival rates for clear 
    cell cancer are much better for other types of cancer and challenged its reliability. 
    Particularly given the significance of the survival rates issue to the outcome 
    of the trial, the trial judge was not entitled to simply adopt the article's 
    conclusion without a more analytical reference to the appellants experts 
    evidence.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [100]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> Accepting 
    that Mrs. Armstrongs cancer must have progressed to at least stage I c, I 
    agree that the trial judge erred by failing to make a finding concerning the 
    evidence that was adduced relating to the applicable survival rate for that 
    specific sub-stage. However, while I also agree that the trial judge erred 
    by relying on statistical evidence of the overall survival rates for ovarian 
    cancer without referring more extensively to the evidence of Drs. Kaizer and 
    De Petrillo, I cannot foreclose the possibility of the trial judge reasonably 
    rejecting their evidence and holding that the evidence relating to overall 
    survival rates for ovarian cancer was properly applicable. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [101]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> In 
    my view, it was open to the trial judge to assess the reliability of the appellants 
    experts evidence taking account of the paucity of available data and to consider 
    whether, in that context, the actuarial statistics concerning the overall 
    survival rates for ovarian cancer were a more reliable measure. Further, the 
    Clinics of North America article provided at least some evidence that the 
    overall survival rate for stage I clear cell ovarian cancer surpasses the 
    threshold of more probable than not. However, it was for the trial judge 
    to assess the reliability of the whole of this evidence, and he failed to 
    do so.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b>iii) Did 
    the trial judge err by ignoring evidence that Mrs. Armstrong did not return 
    to see Dr. Huh following the August 14, 1998 ultrasound?</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [102]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> Even 
    if Dr. Huh breached the standard of care relating to diagnosis, I conclude 
    that the trial judge erred by ignoring the evidence that Mrs. Armstrong did 
    not return to see Dr. Huh following the August 14, 1998 ultrasound and by 
    failing to hold that there was a break in the chain of causation. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [103]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> As 
    already noted, at the time of ordering the August 14, 1998 ultrasound, Dr. 
    Huh indicated that Mrs. Armstrong would require a laparoscopy if the ultrasound 
    was abnormal. According to Dr. Huh, upon her return from vacation, she received 
    a telephone message indicating that Mrs. Armstrong had consulted Dr. Sheriton 
    and that Dr. Sheriton would be performing a laparoscopy. Although Mrs. Armstrong 
    testified that she asked Dr. Huh to attend the laparoscopy for moral support, 
    Mrs. Armstrongs evidence does not undermine Dr. Huhs claim that she learned 
    of Dr. Sheritons involvement when she returned from vacation. Moreover, Mrs. 
    Armstrong did not claim that she asked Dr. Huh to attend the procedure for 
    a medical purpose. In the face of this evidence, I see no basis for the respondents 
    suggestion that Dr. Huh abandoned Mrs. Armstrong. In any event, the trial 
    judge did not make that finding.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [104]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> Dr. 
    Hodd testified that direct examination of the pelvic organs is the best method 
    of detecting cancer. Although he also testified that transvaginal (as opposed 
    to pelvic) ultrasound would have been a preferable diagnostic procedure, and 
    that a laparotomy should have been performed rather than a laparoscopy, the 
    trial judge did not make those findings. Further, although the trial judge 
    noted that Dr. Huh did not perform bi-manual pelvic examinations on Mrs. Armstrongs 
    second and third visits, he made no findings concerning the likely outcome 
    of such examinations nor did he find that a negative outcome should have changed 
    Dr. Huhs plan to proceed to a diagnostic laporoscopy. Accordingly, given 
    that Dr. Huh learned that Dr. Sheriton was going to carry out a diagnostic 
    laparoscopy (the procedure she planned in the event of a negative ultrasound 
    report), I conclude that the trial judge ignored evidence creating a break 
    in the chain of causation and I see no basis for holding that any breach of 
    the standard of care by Dr. Huh was a material contributing factor to any 
    injury that Mrs. Armstrong suffered.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b>iv) Other 
    grounds of appeal </b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [105]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> In 
    addition to the dispositive issues, the appellants raised three other issues 
    on appeal. Although it is not strictly necessary that I deal with these issues, 
    I will comment briefly on the first two because of their importance to the 
    parties. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [106]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> First, 
    Dr. Huh raised an issue that the trial judges finding was unreasonable that 
    she (Dr. Huh) breached the standard of care by failing to revise her working 
    diagnosis after receiving the negative laboratory results.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [107]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> I 
    agree that the trial judge appears to have analyzed the standard of care issue 
    in relation to Dr. Huh on the basis that her working diagnosis was acute, 
    rather than chronic, pelvic inflammatory disease.<a style='mso-footnote-id:
ftn11' href="#_ftn11" name="_ftnref11" title=""><span
class=MsoFootnoteReference><span style='mso-special-character:footnote'> [11] 
    </span></span></a> I also agree that, in the face of substantial evidence 
    to the contrary, the trial judge failed to properly explain his finding. In 
    addition, since all of the medical witnesses agreed that infection is not 
    a necessary component of chronic pelvic inflammatory disease, there was no 
    evidence capable of supporting the trial judges finding that negative laboratory 
    results could rule it out. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [108]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> However, 
    the trial judges findings in relation to the standard of care issue were 
    not limited to his conclusion that Dr. Huh ought to have revised her working 
    diagnosis upon receiving the negative laboratory results. Rather, they included 
    findings that Dr. Huhs original working diagnosis of pelvic inflammatory 
    disease was reasonable and that once she had received the negative laboratory 
    results, a proper differential diagnosis would have included cancer as a possible 
    source of the inflammation known to be present in Mrs. Armstrong's pelvis.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [109]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> The 
    trial judges error in interpreting Dr. Huhs working diagnosis as meaning 
    acute pelvic inflammatory disease affects not only his finding that Dr. Huh 
    should have revised her working diagnosis, but also his finding that it was 
    reasonable. In order to fully determine this ground of appeal, this court 
    would have to make a finding concerning the reasonableness of Dr. Huhs original 
    diagnosis. As that finding is more properly made by a trial judge, and as 
    it is unnecessary that I determine this ground of appeal, I decline to do 
    so.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [110]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> Second, 
    Dr. Sheriton raised an issue that the trial judges finding is unreasonable 
    that the diagnostic laparoscopy ruled out pelvic inflammatory disease. I agree 
    that Dr. Sheriton was consistent in testifying that the adhesions that he 
    and Dr. Mohan saw were the sequela of a prior chronic pelvic inflammatory 
    disease and that Dr. Sheritons comment that once the adhesions were lysed, 
    there was no disease to be found was not an assertion that Mrs. Armstrong 
    had never had pelvic inflammatory disease. However, on my review of the record, 
    the implication of Dr. Sheritons reference to a prior pelvic inflammatory 
    disease in relation to Mrs. Armstrongs ongoing inflammation is unclear. 
    Because I consider that Dr. Hodds evidence was capable of supporting a finding 
    that Mrs. Armstrong did not have chronic pelvic inflammatory disease, and 
    that at most the trial judges erroneous interpretation of Dr. Sheritons 
    evidence could bolster the decision to order a new trial, it is unnecessary 
    that I analyze this issue further.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [111]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> Finally, 
    the appellants also raised an issue concerning whether the trial judge erred 
    by failing to apply a contingency to the damages he awarded to take account 
    of Mrs. Armstrong's chances for survival. In light of my conclusions concerning 
    the second ground of appeal, it is unnecessary that I deal with this issue.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b>v) Caveat 
    concerning the appellants interpretation of the trial judges reasons.</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [112]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> Contrary 
    to the appellants submissions, the respondents contend that the trial judge 
    did not find either that Mrs. Armstrongs cancer was detectable between June 
    and September 1998 or that cancer was causing Mrs. Armstrongs inflammation 
    and adhesions. Rather, the respondents say that the trial judge found only 
    that once pelvic inflammatory disease was ruled out the appellants had a duty 
    to continue investigating the cause of the inflammation and adhesions and 
    would likely have found cancer had they done so. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [113]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> At 
    the appeal hearing the parties did not make submissions highlighting their 
    differing interpretations of the trial judges reasons or addressing which 
    interpretation is correct. For reasons that I will explain, even if the respondents 
    interpretation is correct, that would not change my proposed disposition of 
    this appeal. It is therefore unnecessary that I determine which interpretation 
    is correct. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [114]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> Dealing 
    with the third ground of appeal relating to Dr. Huh, the disputed findings 
    (that Mrs. Armstrong had detectable stage I ovarian cancer while under the 
    appellants care and that cancer was causing Mrs. Armstrongs inflammation 
    and adhesions) have no bearing on whether there was a break in the chain of 
    causation. Accordingly, whichever interpretation of the trial judges reasons 
    is adopted, Dr. Huh is entitled to an order dismissing the respondents claim 
    against her. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [115]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> As 
    for the first and second grounds of appeal, if the respondents interpretation 
    is correct and the trial judge did not make a finding that Mrs. Armstrongs 
    cancer was detectable between June and September 1998, the trial judges reasons 
    must be sustainable assuming that her cancer was detectable during that period 
    and also assuming that it was not. For the following reasons, I conclude that 
    the trial judges reasons are not sustainable based on either assumption.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:
none'><b>a) the respondents interpretation of the trial judges reasons, assuming 
    Mrs. Armstrongs cancer was detectable</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [116]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> Assuming 
    that Mrs. Armstrongs cancer was detectable because tissue samples or washings 
    taken during the laparoscopy from sources external to the ovaries would have 
    revealed cancerous cells (meaning that Mrs. Armstrongs cancer had progressed 
    to at least stage I c), as I have explained, the trial judge misapprehended 
    or ignored the appellants experts evidence concerning stage I c survival 
    rates. Further, if Mrs. Armstrongs cancer was detectable because visual examination 
    during the laparoscopy would have revealed a macroscopically detectable abnormality, 
    as I have explained, the trial judge failed to give sufficient reasons for 
    rejecting Dr. Mohans evidence that on September 1, 1998, Mrs. Armstrongs 
    ovaries appeared healthy.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [117]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> Absent 
    positive washings or tissue samples taken from a source external to the ovaries 
    or an abnormality detectable upon visual inspection or by ultrasound, in my 
    view, there is no basis for concluding either that Mrs. Armstrongs cancer 
    was detectable or that Dr. Sheriton breached the standard of care by failing 
    to remove Mrs. Armstrong's ovaries. In particular, although Dr. Hodd testified 
    that it would have been appropriate to biopsy Mrs. Armstrong's ovaries even 
    if they appeared healthy, he gave no evidence contradicting Dr. Kaizers evidence 
    that up to 1,000 sections could be necessary to find a microscopic tumour.<a
style='mso-footnote-id:ftn12' href="#_ftn12" name="_ftnref12" title=""><span
class=MsoFootnoteReference><span style='mso-special-character:footnote'> [12] 
    </span></span></a> Moreover, the respondents did not challenge the trial judges 
    finding that Dr. Sheriton was not required to excise organs that he believed 
    were healthy. </p>
  <p class=headingNUMBER style='line-height:normal;mso-list:
none'><b>b) the respondents interpretation of the trial judges reasons, assuming 
    Mrs. Armstrongs cancer was not detectable</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [118]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> Assuming 
    Mrs. Armstrong's cancer was not detectable on September 1, 1998, in the absence 
    of specific evidence establishing that Dr. Sheriton would probably have discovered 
    Mrs. Armstrong's cancer in time to save her life, a conclusion that Dr. Sheriton 
    was negligent would be speculative. </p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b><span
style='color:black'>IV. Disposition</span></b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [119]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> <span
style="mso-spacerun: yes"> </span>Based on the foregoing reasons, I would set 
    aside the judgment against the appellants, dismiss the claim against Dr. Huh, 
    and order a new trial of the claim against Dr. Sheriton. In addition, I would 
    award costs of the appeal to the appellants on a partial indemnity scale fixed 
    in the amount of $25,000 inclusive of disbursements and applicable G.S.T.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'><b>RELEASED: 
    </b>June 13, 2005 JS</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'>Janet Simmons 
    J.A.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'>I agree E.E. 
    Gillese J.A.</p>
  <p class=headingNUMBER style='line-height:normal;mso-list:none'>I agree P.C. 
    Hennessy J. (<i>ad hoc</i>)</p>
  <br clear=all style='page-break-before:always'>
  <h4 align=center style='text-align:center;line-height:normal'><span lang=EN-US>Appendix 
    A</span></h4>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l26 level1 lfo76;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> The term <i>pelvic inflammatory disease usually conveys to 
    members of the medical profession that a womans pelvic organs</i>, the ovaries 
    and fallopian tubes, <i>are inflamed as a result of sexually transmitted infection</i> 
    such as gonorrhea or chlamydia. [para. 27].</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l26 level1 lfo76;'> <span
style='font-family:Wingdings;mso-bidi-font-style:italic'>§<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> <i>Dr. Huh testified that she told Ms. Armstrong she had ruled 
    out a current venereal infection upon receiving negative results </i>of gonorrhea 
    and chlamydia swabs she submitted to the laboratory. Tragically, <i>Ms. Armstrong</i> 
    did not understand that, if she was told. She <i>believes her doctors persisted 
    in that belief. And it appears she may be right. </i>[para. 28].<i></i></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l26 level1 lfo76;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Dr. Huh saw Ms. Armstrong first on June 9, 1998 at the emergency 
    department of the Centenary Health Centre<i>She testified that she thought 
    Ms. Armstrong had pelvic inflammatory disease caused by infection</i>, and 
    she took vaginal swabs to test for gonorrhea and chlamydia. [para. 31].</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l26 level1 lfo76;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> <i>The cultures</i> from the swabs taken June 9 returned negative 
    findings, indicating there was no currently active infectionThey <i>proved 
    that she did not have the suspected infection when she first saw Dr. Huh</i>. 
    The antibiotic action of the medications she prescribed could not have been 
    responsible for the relief from pain Nancy reported on July 10. [para. 33].</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l26 level1 lfo76;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> At the July 10 visit, Dr. Huh <i>made a mistaken diagnosis 
    of chronic pelvic inflammatory disease</i> with secondary pelvic adhesions, 
    <i>meaning she thought the adhesions were caused by venereal infection</i> 
    [para. 34].</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l26 level1 lfo76;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> On July 10 Dr. Huh <i>noted her impression chronic p.i.d</i>. 
    No pain now. Suggest HIV, VRDL. Do not recommend hysterectomy at present. 
    To use condoms. The notation suggest HIV, VRDL meant that she recommended 
    blood tests for HIV and syphilis. Blood was drawn from both [Mr. and Mrs. 
    Armstrong], and the tests were performed for that purpose, with negative results. 
    Dr. Huh testified that she recommended the use of condoms not as a safeguard 
    from infecting each other but because of the discussion she and Mrs. Armstrong 
    had about the use of sex toys. I am unable to accept this evidence. The syphilis 
    screening test is stamped received July 15, HIV test result indicates date 
    reported 27 July 1998. I find Dr. Huh would have recommended condom use at 
    least until the latter report was received<span
style="mso-spacerun: yes">  </span>[para. 35].</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l26 level1 lfo76;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> <i>The negative lab tests</i> on these blood samples and the 
    swabs taken June 9 <i>showed that there was no active infectious process to 
    explain the inflammation</i> and adhesions in [Mrs. Armstrong's] pelvis, <i>that 
    is no pelvic inflammatory disease in the sense in which the term is generally 
    understood</i>. <i>While it may have been a reasonable working diagnosis until 
    the results were known, thereafter it was no longer reasonable to keep it 
    as the primary diagnosis.</i> Dr. Huh appears to have believed that the antibiotic 
    medications she had prescribed had brought a venereal infection under control, 
    while the reality can only be that there was no such infection present to 
    begin with, as the lab tests proved. Dr. Huh had a duty to recognize that 
    in change the working diagnosis there was recurring inflammation, but it 
    was not caused by infection, much less venereal infection. Its cause was not 
    properly investigated. Still no differential diagnosis was postulated. [para. 
    36].</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l26 level1 lfo76;'> <span
style='font-family:Wingdings;mso-bidi-font-weight:bold'>§<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Another visit was arranged for August 6. Dr. Huh noted that 
    Mrs. Armstrong had abdominal pain the previous week, with constipation. She 
    had also had fever, which Dr. Huh attributed to an upper respiratory infection 
    (URI). She noted O/E abdo benign - meaning on examination she found no abnormality 
    of the abdomen.<span style="mso-spacerun: yes">  </span>[para. 38].</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal;mso-list:l26 level1 lfo76;'> <span
style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> She noted <i>I (for impression)-not likely related to chronic 
    P.I.D</i> <i>Dr. Huh's impression was that Ms. Armstrong's distress was 
    not related to her chronic P.I.D.</i> but she did not record whether she thought 
    of any alternative [emphasis added]<span style="mso-spacerun: yes">  </span>[para. 
    39].</p>
  <h4 align=left style='text-align:left;line-height:normal'><span lang=EN-US
style='font-weight:normal;mso-bidi-font-weight:bold'> &nbsp; </span></h4>
</div>
<div style='mso-element:footnote-list'> <br clear=all>
  <hr align=left size=1 width="33%">
  <div style='mso-element:footnote' id=ftn1> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn1' href="#_ftnref1"
name="_ftn1" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [1] </span></span></a> Ascites refer to an accumulation of fluid in 
      the peritoneal cavity. Their presence in small amounts is normal as </p>
    <p class=MsoFootnoteText>their purpose is to lubricate the surfaces of internal 
      organs. The inability of organs to absorb ascites indicates disease.</p>
  </div>
  <div style='mso-element:footnote' id=ftn2> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn2' href="#_ftnref2"
name="_ftn2" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [2] </span></span></a> Peritoneal washings refer to collections of 
      fluid taken during surgery when malignancy is suspected; the peritoneal 
      cavity is washed with saline solution, which is then sent to pathology to 
      test for the presence of cancer cells.</p>
  </div>
  <div style='mso-element:footnote' id=ftn3> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn3' href="#_ftnref3"
name="_ftn3" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [3] </span></span></a> The tests included vaginal swabs for gonorrhea 
      and chlamydia taken by Dr. Huh on June 9, 1998, and blood tests for HIV 
      and syphilis carried out after a July 10, 1998 appointment with Dr. Huh.</p>
  </div>
  <div style='mso-element:footnote' id=ftn4> 
    <p class=MsoFootnoteText align=left style='text-align:left'><a
style='mso-footnote-id:ftn4' href="#_ftnref4" name="_ftn4" title=""><span
class=MsoFootnoteReference><span style='mso-special-character:footnote'> [4] </span></span></a> 
      In addition to the foregoing findings, the trial judge made other findings 
      concerning breaches of the standard of care<i>.</i> For example, the trial 
      judge found that Dr. Sheriton breached the standard of care because he did 
      not conduct tests which were reasonable in light of what he knew or should 
      have known and he did not report on the results of<span style='background:fuchsia;
mso-highlight:fuchsia'> </span>Mrs. Armstrongs surgery to those who might have 
      helped her. In my view, however, the findings that are most relevant to 
      the trial judges ultimate determination of liability and to the issues 
      on appeal are those set out above.</p>
  </div>
  <div style='mso-element:footnote' id=ftn5> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn5' href="#_ftnref5"
name="_ftn5" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [5] </span></span></a> Depending on the quantity, fluid can be an indicator 
      of inflammation.</p>
  </div>
  <div style='mso-element:footnote' id=ftn6> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn6' href="#_ftnref6"
name="_ftn6" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [6] </span></span></a> As noted by the trial judge, this means that 
      Mrs. Armstrong did not actually have appendicitis.</p>
  </div>
  <div style='mso-element:footnote' id=ftn7> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn7' href="#_ftnref7"
name="_ftn7" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [7] </span></span></a> One of the appellants experts, Dr. Owolabi, 
      explained that ultrasound creates images based on a wavelength of light 
      and a resulting echo. It is the echo that is traced out as an image and 
      that shows the structures consistency. </p>
  </div>
  <div style='mso-element:footnote' id=ftn8> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn8' href="#_ftnref8"
name="_ftn8" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [8] </span></span></a> P. J. Di Saia &amp; W. T. Creasman, <i style='mso-bidi-font-style:normal'>Clinical 
      Gynecologic Oncology,</i><span style='mso-bidi-font-style:italic'> 5<sup>th</sup><span
style="mso-spacerun: yes">  </span>ed. (St. Louis, MO: J. B. Mosloy &amp; Co., 
      1997).</span></p>
  </div>
  <div style='mso-element:footnote' id=ftn9> 
    <p class=headingNUMBER style='line-height:normal;mso-list:none'><a
style='mso-footnote-id:ftn9' href="#_ftnref9" name="_ftn9" title=""><span
class=MsoFootnoteReference><span style='mso-special-character:footnote'> [9] </span></span></a> 
      <span style='font-size:10.0pt'>The appellants called one other expert witness 
      at trial, Dr. Marcaccio, the chief of surgery with the Hamilton Health Sciences 
      Corporation. His evidence related primarily to whether Dr. Walkovichs treatment 
      of Mrs. Armstrong met the standard of care of a practising general surgeon.</span></p>
  </div>
  <div style='mso-element:footnote' id=ftn10> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn10' href="#_ftnref10"
name="_ftn10" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [10] </span></span></a> The trial judge relied on the following survival 
      statistics set out in Di Saia &amp; Creasman,<i> supra</i><span style='mso-bidi-font-style:italic'>: 
      stage I a-83.5%; Stage I b- 79.3% and stage I c-73.1%.</span><i style='mso-bidi-font-style:
normal'></i></p>
  </div>
  <div style='mso-element:footnote' id=ftn11> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn11' href="#_ftnref11"
name="_ftn11" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [11] </span></span></a> The portions of the trial judge's reasons that 
      illustrate this approach are set out in appendix A.</p>
    <p class=MsoFootnoteText>Although Dr. Hodd agreed with a suggestion by the 
      trial judge that the term pelvic inflammatory disease is somewhat of a code 
      for sexually transmitted disease, Dr. Hodd did not suggest that meaning 
      is confined to current infections. On the contrary, he specifically explained 
      that laboratory cultures for sexually transmitted disease would almost certainly 
      be negative in cases of chronic pelvic inflammatory disease unless there 
      was a reinfection.</p>
  </div>
  <div style='mso-element:footnote' id=ftn12> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn12' href="#_ftnref12"
name="_ftn12" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [12] </span></span></a> Dr. Kaizer referred specifically to a tumour 
      that was one millimetre in size.</p>
  </div>
</div>
</body>
</html>
